510(k) K890423

V-TREND TARGET CRP TEST by Texas Immunology, Inc. — Product Code DCK

K890423 is an FDA 510(k) premarket notification submitted by Texas Immunology, Inc. for the device "V-TREND TARGET CRP TEST". The FDA issued a decision of Substantially Equivalent on February 17, 1989. The device falls under product code DCK (C-Reactive Protein, Antigen, Antiserum, And Control), a Class II device regulated under 21 CFR 866.5270. Texas Immunology, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
February 17, 1989
Date Received
January 26, 1989
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
C-Reactive Protein, Antigen, Antiserum, And Control
Device Class
Class II
Regulation Number
866.5270
Review Panel
IM
Submission Type